<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39356939</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2317-6385</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Einstein (Sao Paulo, Brazil)</Title><ISOAbbreviation>Einstein (Sao Paulo)</ISOAbbreviation></Journal><ArticleTitle>Fatality from COVID-19 does not affect palliative care duration among patients with advanced cancer: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>eAO0536</StartPage><MedlinePgn>eAO0536</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">eAO0536</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.31744/einstein_journal/2024AO0536</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1679-45082024000100237</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Jomar et al. demonstrated that death due to COVID-19 did not affect the time under exclusive palliative care among patients with advanced cancer, even during the first year of the pandemic caused by a hitherto little-known disease.</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">◼ Fatality due to COVID-19 does not alter the time under oncological palliative care.</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">◼ The retrospective design of this pioneering study allows causal inference.</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">◼ Access to oncological palliative care frequently approaches terminality of life.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed at investigating the extent to which COVID-19-induced fatalities affect the duration of palliative care among patients with advanced cancer.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective cohort study was conducted at the Palliative Care Unit of the Brazilian Instituto Nacional de Câncer in Rio de Janeiro, Brazil, on 1,104 advanced cancer patients who died under exclusive palliative care between March 11, 2020, and March 31, 2021. Wilcoxon rank-sum (Mann-Whitney U) and log-rank tests were performed to examine statistical differences between the medians of time, and the Kaplan-Meier estimator was used to graphically illustrate survival over time under exclusive palliative care contingent upon the underlying causes of death of the two experimental groups (cancer versus COVID-19).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 133 (12.05%) patients succumbed to COVID-19. In both groups, the median time under exclusive palliative care was less than one month. The exclusive palliative care survival curves did not exhibit any statistically significant difference between the groups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Death due to COVID-19 did not modify the duration of exclusive palliative care among patients with advanced cancer.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jomar</LastName><ForeName>Rafael Tavares</ForeName><Initials>RT</Initials><Identifier Source="ORCID">0000-0002-4101-7138</Identifier><AffiliationInfo><Affiliation>Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marques</LastName><ForeName>Jéssica Thaís Nascimento</ForeName><Initials>JTN</Initials><Identifier Source="ORCID">0000-0002-5819-5395</Identifier><AffiliationInfo><Affiliation>Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Livia Costa de</ForeName><Initials>LC</Initials><Identifier Source="ORCID">0000-0002-5052-1846</Identifier><AffiliationInfo><Affiliation>Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendes</LastName><ForeName>Gelcio Luiz Quintella</ForeName><Initials>GLQ</Initials><Identifier Source="ORCID">0000-0001-9564-0892</Identifier><AffiliationInfo><Affiliation>Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cunha</LastName><ForeName>Daianny Arrais de Oliveira da</ForeName><Initials>DAOD</Initials><Identifier Source="ORCID">0000-0003-2109-319X</Identifier><AffiliationInfo><Affiliation>Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guimarães</LastName><ForeName>Raphael Mendonça</ForeName><Initials>RM</Initials><Identifier Source="ORCID">0000-0003-1225-6719</Identifier><AffiliationInfo><Affiliation>Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Einstein (Sao Paulo)</MedlineTA><NlmUniqueID>101281800</NlmUniqueID><ISSNLinking>1679-4508</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010166" MajorTopicYN="Y">Palliative Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of interest:</b> none.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>22</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>15</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39356939</ArticleId><ArticleId IdType="pmc">PMC11461002</ArticleId><ArticleId IdType="doi">10.31744/einstein_journal/2024AO0536</ArticleId><ArticleId IdType="pii">S1679-45082024000100237</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Islam N, Shkolnikov VM, Acosta RJ, Klimkin I, Kawachi I, Irizarry RA, et al. Excess deaths associated with covid-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countries. BMJ. 2021;373(1137):n1137–n1137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8132017</ArticleId><ArticleId IdType="pubmed">34011491</ArticleId></ArticleIdList></Reference><Reference><Citation>Riera R, Bagattini AM, Pacheco RL, Pachito DV, Roitberg F, Ilbawi A. Delays and disruptions in cancer health care due to COVID-19 pandemic: systematic review. JCO Glob Oncol. 2021;7(7):311–323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8081532</ArticleId><ArticleId IdType="pubmed">33617304</ArticleId></ArticleIdList></Reference><Reference><Citation>Jardim BC, Migowski A, Corrêa FM, Silva GA. Covid-19 in Brazil in 2020: impact on deaths from cancer and cardiovascular diseases. Rev Saude Publica. 2022;56:22–22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9004704</ArticleId><ArticleId IdType="pubmed">35476100</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute for Health Metrics and Evaluations (IHME)   Estimation of total mortality due to COVID-19. Seattle: IHME; 2021.  [cited 2023 Jan 30].  Available from:  http://www.healthdata.org/special-analysis/estimation-excess-mortality-due-covid-19-and-scalars-reported-covid-19-deaths
.</Citation></Reference><Reference><Citation>Ribeiro CM, Correa FM, Migowski A. Short-term effects of the COVID-19 pandemic on cancer screening, diagnosis and treatment procedures in Brazil: a descriptive study, 2019-2020. Epidemiol Serv Saude. 2022;31(1):e2021405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11346577</ArticleId><ArticleId IdType="pubmed">35262614</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Odah H, Su J, Wang M, Lin SR, Bayuo J, Musa SS, et al. Palliative care landscape in the COVID-19 era: bibliometric analysis of global research. Healthcare (Basel) 2022;10(7):1344–1344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9318933</ArticleId><ArticleId IdType="pubmed">35885870</ArticleId></ArticleIdList></Reference><Reference><Citation>Organização Pan-Americana da Saúde (OPAS)   Histórico da pandemia de COVID-19. Washington: OPAS; 2020.  [cited 2023 Jan 30].  Available from:  https://www.paho.org/pt/covid19/historico-da-pandemia-covid-19#:~:text=25%20de%20abril%20de%202009,2014%3A%20dissemina%C3%A7%C3%A3o%20internacional%20de%20poliov%C3%ADrus
.</Citation></Reference><Reference><Citation>World Health Organization (WHO)   International guidelines for certification and classification (coding) of COVID-19 as cause of death. Geneva: WHO; 2020.  [cited 2023 Jan 30].  Available from:  https://www.who.int/publications/m/item/international-guidelines-for-certification-and-classification-(coding)-of-covid-19-as-cause-of-death
.</Citation></Reference><Reference><Citation>Globo Comunicação e Participações S.A  . Brasil registra quase 4 mil mortes por Covid no dia e fecha pior mês da pandemia com 66,8 mil óbitos. Rio de Janeiro: G1 Rio; 2021.  [citado 2023 Jan 30].  Disponível em:  https://g1.globo.com/bemestar/coronavirus/noticia/2021/03/31/brasil-registra-quase-4-mil-mortes-por-covid-no-dia-e-fecha-pior-mes-da-pandemia-com-668-mil-obitos.ghtml
.</Citation></Reference><Reference><Citation>World Health Organization (WHO)   Weekly epidemiological update on COVID-19 - 30 March 2021. Geneva: WHO; 2021.  [cited 2023 Jan 30].  Available from:  https://www.who.int/publications/m/item/weekly-epidemiological -update-on-covid-19---31-march-2021
.</Citation></Reference><Reference><Citation>Globo Comunicação e Participações S.A  . Com 3.647 mortes por Covid, março é o 4° pior mês da pandemia no RJ. Rio de Janeiro: G1 Rio; 2021.  [citado 2023 Jan 30].  Disponível em:  https://g1.globo.com/rj/rio-de-janeiro/noticia/2021/03/31/com-3648-mortes-por-covid-marco-e-o-4-pior-mes-da-pandemia-no-rj.ghtml
.</Citation></Reference><Reference><Citation>Horlait M, Chambaere K, Pardon K, Deliens L, Van Belle S. What are the barriers faced by medical oncologists in initiating discussion of palliative care? A qualitative study in Flanders, Belgium. Support Care Cancer. 2016;24(9):3873–3881.</Citation><ArticleIdList><ArticleId IdType="pubmed">27086311</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui D, Kim SH, Kwon JH, Tanco KC, Zhang T, Kang JH, et al. Access to palliative care among patients treated at a comprehensive cancer center. Oncologist. 2012;17(12):1574–1580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3528390</ArticleId><ArticleId IdType="pubmed">23220843</ArticleId></ArticleIdList></Reference><Reference><Citation>Wentlandt K, Krzyzanowska MK, Swami N, Rodin GM, Le LW, Zimmermann C. Referral practices of oncologists to specialized palliative care. J Clin Oncol. 2012;30(35):4380–4386.</Citation><ArticleIdList><ArticleId IdType="pubmed">23109708</ArticleId></ArticleIdList></Reference><Reference><Citation>Beernaert K, Cohen J, Deliens L, Devroey D, Vanthomme K, Pardon K, et al. Referral to palliative care in COPD and other chronic diseases: a population-based study. Respir Med. 2013;107(11):1731–1739.</Citation><ArticleIdList><ArticleId IdType="pubmed">23810150</ArticleId></ArticleIdList></Reference><Reference><Citation>Charalambous H, Pallis A, Hasan B, O’Brien M. Attitudes and referral patterns of lung cancer specialists in Europe to Specialized Palliative Care (SPC) and the practice of Early Palliative Care (EPC) BMC Palliat Care. 2014;13(1):59–59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4279692</ArticleId><ArticleId IdType="pubmed">25550683</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YJ, Yang JH, Lee JW, Yoon J, Nah JR, Choi WS, et al. Association between the duration of palliative care service and survival in terminal cancer patients. Support Care Cancer. 2015;23(4):1057–1062.</Citation><ArticleIdList><ArticleId IdType="pubmed">25281228</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitas R, Oliveira LC, Mendes GL, Lima FL, Chaves GV. Barreiras para o encaminhamento para o cuidado paliativo exclusivo: a percepção do oncologista. Saúde Debate. 2022;46(133):331–345.</Citation></Reference><Reference><Citation>Silva GA, Wiegert EV, Calixto-Lima L, Oliveira LC. Clinical utility of the modified Glasgow Prognostic Score to classify cachexia in patients with advanced cancer in palliative care. Clin Nutr. 2020;39(5):1587–1592.</Citation><ArticleIdList><ArticleId IdType="pubmed">31377013</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiegert EV, de Oliveira LC, Calixto-Lima L, Mota E Silva Lopes MS, Peres WA. Cancer cachexia: comparing diagnostic criteria in patients with incurable cancer. Nutrition. 2020;79-80:110945–110945.</Citation><ArticleIdList><ArticleId IdType="pubmed">32927241</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltran-Aroca CM, Ruiz-Montero R, Llergo-Muñoz A, Rubio L, Girela-López E. Impact of the COVID-19 pandemic on palliative care in cancer patients in Spain. Int J Environ Res Public Health. 2021;18(22):11992–11992.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8618945</ArticleId><ArticleId IdType="pubmed">34831747</ArticleId></ArticleIdList></Reference><Reference><Citation>Everitt R, Robinson N, Marco D, Weil J, Bryan T. Increased number of deaths within 24 h of admission during a period of social restriction related to the COVID-19 pandemic: A retrospective service evaluation in a metropolitan palliative care unit. Palliat Med. 2021;35(8):1508–1513.</Citation><ArticleIdList><ArticleId IdType="pubmed">34159860</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira LC, da Costa Rosa KS, Borsatto AZ, de Oliveira LA, de Freitas R, Dos Santos Machado Sampaio SG. Prognostic factors in patients with advanced cancer and COVID-19: a cohort from the Palliative Care Unit of the Brazilian National Cancer Institute. Support Care Cancer. 2021;29(10):6005–6012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005668</ArticleId><ArticleId IdType="pubmed">33779801</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>